Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FOR IMMEDIATE RELEASE
Sundial Announces Share Repurchase Program
Calgary, AB (November 11, 2021) – Sundial Growers (Nasdaq: SNDL) (“Sundial” or the “Company”) announced today that that its Board of Directors (the “Board”) has approved a new share repurchase program (the “Share Repurchase Program”) which authorizes the Company to repurchase up to C$100 million (the “Share Repurchase Amount”) of its outstanding common shares ("shares") from time to time at prevailing market prices, enabling Sundial to opportunistically return value to shareholders.
Pursuant to the Share Repurchase Program, Sundial may purchase shares from time to time at the discretion of management through open market purchases, privately negotiated transactions, block trades, derivatives, accelerated or other structured share repurchase programs, or other means. The manner, timing, pricing and amount of any transactions will be subject to the discretion of Sundial and may be based upon market conditions, regulatory requirements and alternative opportunities that Sundial may have for the use or investment of its capital.
Notwithstanding the Share Repurchase Amount, Sundial may only purchase a maximum of 102.8 million shares under the Share Repurchase Program, representing approximately 5% of the issued and outstanding shares as at the date hereof. Subject to the foregoing limitations, the Share Repurchase Program will commence on November 19, 2021 and expire on November 19, 2022. The Share Repurchase Program does not require the Company to purchase any minimum number of shares, and repurchases may be suspended or terminated at any time at the Company’s discretion.
The actual number of shares which may be purchased pursuant to the Share Repurchase Program and the timing of any purchases will be determined by management and the Board.
The price which the Company will pay for any such shares will be the prevailing market price at the time of acquisition, subject to certain limitations imposed by applicable securities laws. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation, and all such purchases will be made on the open market through the facilities of Nasdaq or by such other means as may be permitted under applicable securities laws during the term of the Share Repurchase Program.
About Sundial Growers Inc.
Sundial is a public company with Common Shares traded on Nasdaq under the symbol "SNDL”. Our business is reported and analyzed under three operating segments: Cannabis Operations, Cannabis Retail and Investments.
As a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities, our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced growers set us apart. Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. Spiritleaf aims to be the most knowledgeable and trusted source of recreational cannabis by offering a premium consumer experience and quality curated cannabis products.
Our investment operations seek to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.
We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds and Rocky View County, Alberta, Canada. For more information on Sundial, please go to www.sndlgroup.com.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward looking statements in this release include, but are not limited to, the number of shares to be repurchased, and the method of such repurchases, if any, pursuant to the Share Repurchase Program. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
For more information:
Sophie Pilon, Corporate Communications
Sundial Growers Inc.
O: 1.587.327.2017
E: spilon@sundialgrowers.com
FOR IMMEDIATE RELEASE
Sundial Announces Share Repurchase Program
Calgary, AB (November 11, 2021) – Sundial Growers (Nasdaq: SNDL) (“Sundial” or the “Company”) announced today that that its Board of Directors (the “Board”) has approved a new share repurchase program (the “Share Repurchase Program”) which authorizes the Company to repurchase up to C$100 million (the “Share Repurchase Amount”) of its outstanding common shares ("shares") from time to time at prevailing market prices, enabling Sundial to opportunistically return value to shareholders.
Pursuant to the Share Repurchase Program, Sundial may purchase shares from time to time at the discretion of management through open market purchases, privately negotiated transactions, block trades, derivatives, accelerated or other structured share repurchase programs, or other means. The manner, timing, pricing and amount of any transactions will be subject to the discretion of Sundial and may be based upon market conditions, regulatory requirements and alternative opportunities that Sundial may have for the use or investment of its capital.
Notwithstanding the Share Repurchase Amount, Sundial may only purchase a maximum of 102.8 million shares under the Share Repurchase Program, representing approximately 5% of the issued and outstanding shares as at the date hereof. Subject to the foregoing limitations, the Share Repurchase Program will commence on November 19, 2021 and expire on November 19, 2022. The Share Repurchase Program does not require the Company to purchase any minimum number of shares, and repurchases may be suspended or terminated at any time at the Company’s discretion.
The actual number of shares which may be purchased pursuant to the Share Repurchase Program and the timing of any purchases will be determined by management and the Board.
The price which the Company will pay for any such shares will be the prevailing market price at the time of acquisition, subject to certain limitations imposed by applicable securities laws. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation, and all such purchases will be made on the open market through the facilities of Nasdaq or by such other means as may be permitted under applicable securities laws during the term of the Share Repurchase Program.
About Sundial Growers Inc.
Sundial is a public company with Common Shares traded on Nasdaq under the symbol "SNDL”. Our business is reported and analyzed under three operating segments: Cannabis Operations, Cannabis Retail and Investments.
As a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities, our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced growers set us apart. Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. Spiritleaf aims to be the most knowledgeable and trusted source of recreational cannabis by offering a premium consumer experience and quality curated cannabis products.
Our investment operations seek to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.
We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds and Rocky View County, Alberta, Canada. For more information on Sundial, please go to www.sndlgroup.com.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward looking statements in this release include, but are not limited to, the number of shares to be repurchased, and the method of such repurchases, if any, pursuant to the Share Repurchase Program. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
For more information:
Sophie Pilon, Corporate Communications
Sundial Growers Inc.
O: 1.587.327.2017
E: spilon@sundialgrowers.com
.7202 @10:25
? if they bought the company would be acquiring Canadian liquor and cannabis retailer Alcanna for say .70 share price pursuant to which Sundial will acquire all of the issued and outstanding common shares of Alcanna for $9.12 per share for fully diluted consideration of approximately $346 million equates to 494,285,714.2857143 shares of sndl should now lower share count
I THINK 10 - 12 BY THE LAUNCH DATE
I believe in 2020 ge tesla gm ford may look at this.
just think exxon sold assets also now if they buy chk in usa
Real Estate Tycoon Buys Up Oil Assets At Rock Bottom Prices
Oilprice.com
Tsvetana Paraskova
,Oilprice.com•November 14, 2019
Sam Zell, the real estate mogul, has acquired oil assets across the United States at ‘fire-sale’ prices, as U.S. drillers sell assets to raise cash which is scarce in the oil patch these days, the billionaire told Bloomberg TV in an interview on Thursday.
Zell, founder and chairman of Equity Group Investments, has bought assets of oil companies in Texas, Colorado, and California at advantageous prices because firms are increasingly looking to have cash buffers, anticipating potential further slowdown in drilling and cash available to the oil sector.
“The amount of capital available in the oil patch is disappearing,” Zell told Bloomberg, comparing the U.S. oil industry now with the early-1990s real estate sector when no one had cash and there were empty real estates everywhere.
After years of frustration with the lack of meaningful returns from shale firms and amid persistently low oil and gas prices, investors have turned their backs on energy stocks. Banks have too, restricting lending to shale firms who have grown production so far mostly by taking on more debt.
U.S. shale drillers are not optimistic about the near future, either, admitting that Wall Street has turned off the tap on funding and that low oil and gas prices will continue to depress margins and earnings.
In one of the latest signs of distress in the U.S. shale patch, Chesapeake Energy warned last week that its ability to comply with the covenants under its revolving credit facilities and other indebtedness could impact its ability to continue as a going concern.
The company, which helped propel the shale gas revolution in the late 2000s, said it has released its operated rigs and completion crews in the Haynesville Shale for the rest of the year. Chesapeake is also slashing its 2020 capital expenditure forecast by around 30 percent, and expects to reduce 2020 production and general and administrative expenses by some 10 percent.
Reports emerged yesterday that leading Haynesville basin producer Comstock Resources is in discussions to buy the Haynesville assets of Chesapeake in Louisiana.
By Tsvetana Paraskova for Oilprice.com
dose anyone think BP,SHELL CHEVRON WILL ALSO BUY IN TO FUEL CELL ENERGY
Lets lock up trades should move higher
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
MEETING INFORMATION
FRIDAY, DECEMBER 13, 2019
10:00 a.m. Eastern Standard Time
Offices of Foley & Lardner LLP
90 Park Avenue, 35th Floor
New York, NY 10016
ITEMS OF BUSINESS
1.
To approve the amendment of the FuelCell Energy, Inc. Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock of FuelCell Energy, Inc. from 225,000,000 shares to 450,000,000 shares (the “Increase Authorized Shares Proposal”);
?
2.
To authorize the Board of Directors of FuelCell Energy, Inc. to effect a reverse stock split (such authorization to expire on July 14, 2020) through an amendment to the FuelCell Energy, Inc. Certificate of Incorporation, as amended (the “Reverse Stock Split Proposal”); provided that, in the event that the Increase Authorized Shares Proposal is also approved, such reverse stock split and amendment, if implemented by the Board of Directors, will become effective after the effectiveness of the increase in authorized shares pursuant to the Increase Authorized Shares Proposal;
?
3.
To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Increase Authorized Shares Proposal or the Reverse Stock Split Proposal (the “Adjournment Proposal”); and
?
4.
To transact such other business as may properly come before the Special Meeting or any adjournment thereof.
?
RECORD DATE
Holders of record of our common stock on November 1, 2019, the record date, are entitled to notice of, and to vote at, the Special Meeting.
MATERIALS TO REVIEW
This booklet contains our Notice of Special Meeting and our Proxy Statement, which fully describes the business we will conduct at the Special Meeting.
PROXY VOTING
It is important that your shares are represented and voted at the Special Meeting. Please vote your shares according to the instructions under “How to Vote” in the Proxy Summary.
ADMISSION TO THE SPECIAL MEETING
To attend the Special Meeting, please follow the “Meeting Attendance” instructions in the Proxy Summary.
By Order of the Board of Directors,?
[MISSING IMAGE: sg_jenniferd-arasimowicz.jpg]
JENNIFER D. ARASIMOWICZ
Executive Vice President, General Counsel,
Chief Administrative Officer
and Corporate Secretary
November 6, 2019?
ESTIMATE 1.82 BUY FRIDAY
PURA - Puration $0.35 Target Price Recommendation Confirmed by CBD Beverage Industry Survey Final Results
PR Newswire PR Newswire•October 10, 2019
DALLAS, Oct. 10, 2019 /PRNewswire/ -- Puration, Inc. (PURA) today announced the publication of the final results from the Goldman Small Cap Research CBD beverage industry survey (see link below) conducted in conjunction with the PURA's initiative to launch new CBD Infused beer, coffee and tea beverages. Goldman summarizes the results with a confirmation of the $0.35 Price target for the shares of PURA and a Speculative Buy recommendation issued on September 25, 2019 (see link below to Sep 25 Analyst Report).
"Great Entry Point for Emerging Leader. With the stock basing at current levels, even a modest series of news and milestone events should drive the stock toward our price target. Moreover, with strong seasonality in the current quarter, and new markets just opened, PURA has the wind at its back."
"Key Numbers: When asked in order of preference what CBD-infused beverage they would buy, 77 or 31% said tea and 74 or 30% said water. As a provider of water and tea, PURA leadership certainly is providing consumers the most popular categories of CBD-infused beverages which bodes very well for future sales and market share growth."
"The Trend is PURA's Friend: While CBD oils remain the most popular source of CBD products, the data and responses indicate that oils, vapes, and tinctures usage may be swapped on an ever-increasing scale, for edibles and beverages. We expect that they will eventually overtake these product categories which will be a boon to PURA."
"Conclusion: While the interim CBD user survey results were favorable for PURA, the final results were overwhelmingly positive for the Company's future. There are a number of surprising results from this survey, which had a final identifiable respondent tally of 246 participants, as compared with our 85 identifiable responses when we issued interim results. The bottom line is that these results affirm to us that PURA is well-positioned to lead the CBD-infused beverage market and we reiterate our $0.35 price target."
Tomorrow, On Friday, October 11, 2019, PURA will publish an update on the launch of TranquiliTeaCBD and a new coffee infused with CBD in addition to including a progress update on the company's progress toward its 2019 $4 million sales milestone.
PURA has reported over $1 million in CBD beverage sales in the first six months of 2019 after reporting approximately $1 million in sales for all of 2018. On top of its ongoing sales, PURA has signed a new European distribution agreement anticipated to generate $4 million annually with a first shipment scheduled later this month.
To see the full final CBD Beverage industry survey results, follow the link below:
CBD Beverage Industry Results – October 10, 2019
To see the original full Analyst Report, follow the link below:
PURAITON, Inc. Research Analyst Report – September 25, 2019
For more information on Puration, visit http://www.purationinc.com
PURA - Puration $0.35 Target Price Recommendation Confirmed by CBD Beverage Industry Survey Final Results
PR Newswire PR Newswire•October 10, 2019
DALLAS, Oct. 10, 2019 /PRNewswire/ -- Puration, Inc. (PURA) today announced the publication of the final results from the Goldman Small Cap Research CBD beverage industry survey (see link below) conducted in conjunction with the PURA's initiative to launch new CBD Infused beer, coffee and tea beverages. Goldman summarizes the results with a confirmation of the $0.35 Price target for the shares of PURA and a Speculative Buy recommendation issued on September 25, 2019 (see link below to Sep 25 Analyst Report).
"Great Entry Point for Emerging Leader. With the stock basing at current levels, even a modest series of news and milestone events should drive the stock toward our price target. Moreover, with strong seasonality in the current quarter, and new markets just opened, PURA has the wind at its back."
"Key Numbers: When asked in order of preference what CBD-infused beverage they would buy, 77 or 31% said tea and 74 or 30% said water. As a provider of water and tea, PURA leadership certainly is providing consumers the most popular categories of CBD-infused beverages which bodes very well for future sales and market share growth."
"The Trend is PURA's Friend: While CBD oils remain the most popular source of CBD products, the data and responses indicate that oils, vapes, and tinctures usage may be swapped on an ever-increasing scale, for edibles and beverages. We expect that they will eventually overtake these product categories which will be a boon to PURA."
"Conclusion: While the interim CBD user survey results were favorable for PURA, the final results were overwhelmingly positive for the Company's future. There are a number of surprising results from this survey, which had a final identifiable respondent tally of 246 participants, as compared with our 85 identifiable responses when we issued interim results. The bottom line is that these results affirm to us that PURA is well-positioned to lead the CBD-infused beverage market and we reiterate our $0.35 price target."
Tomorrow, On Friday, October 11, 2019, PURA will publish an update on the launch of TranquiliTeaCBD and a new coffee infused with CBD in addition to including a progress update on the company's progress toward its 2019 $4 million sales milestone.
PURA has reported over $1 million in CBD beverage sales in the first six months of 2019 after reporting approximately $1 million in sales for all of 2018. On top of its ongoing sales, PURA has signed a new European distribution agreement anticipated to generate $4 million annually with a first shipment scheduled later this month.
To see the full final CBD Beverage industry survey results, follow the link below:
CBD Beverage Industry Results – October 10, 2019
To see the original full Analyst Report, follow the link below:
PURAITON, Inc. Research Analyst Report – September 25, 2019
For more information on Puration, visit http://www.purationinc.com
DALLAS , Sept. 16, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (USOTC: ALYI) today confirmed a fleet order for an initial 50 electric motorcycles to be delivered in Texas .
.
he recent attention garnered by ALYI for its electric vehicle imitative in Africa where the company continues to develop $300 million in electric vehicle projects, management today reiterates that the company continues to advance similar electric vehicle projects in the United States. Earlier this year the company confirmed it had met a major eclectic motorcycle pilot testing milestone requirement of an overall contract to deliver an initial 50 electric motorcycles in Texas. The contract remains on track. The production version of the original pilot electric motorcycle is anticipated to soon be completed. Management plans to produce and publish a short video of the production electric motorcycles once the production version is finalized.
ALYI CEO Podcast Interview And Analyst Research Report
The company recently an announce a Research Analyst Report update published by Goldman Small Cap Research in conjunction with a podcast interview of CEO Randell Torno with the CEO of the Africa Development Organization , Libasse Diop Dia . Hosted by Goldman, the two CEOs discuss the industrialization of Africa with a focus on the development of clean, sustainable energy. ALYI’s $300 million electric vehicle (EV) initiative in Africa is featured.
Podcast Interview Takeaway: ALYI Offers Even Greater Upside than Originally Anticipated
Alternet Systems, Inc. is today overall focused on offering varied, environmentally sustainable, energy storage solutions for targeted markets, including consumer electric vehicles and military applications.
To listen to the Podcast and view the ALYI Research Report Update, please visit: https://www.goldmanresearch.com/201909101250/Opportunity-Research/new-ceo-podcast-interview.html
For more information, please visit: http://www.alternetsystemsinc.com
Disclaimer/Safe Harbor : This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Alternet Systems, Inc. Contact: Randell Torno info@lithiumip.com +1-800-713-0297
KALY Financials
Valuation
Market Capitalization 14.764M
Enterprise Value (MRQ) -14.647M
Enterprise Value/EBITDA (TTM) -0.5177
Total Shares Outstanding (MRQ) 2.603M
Number of Employees 171
Number of Shareholders 53
Price to Earnings Ratio (TTM) 0.0018
Price to Revenue Ratio (TTM) 0.1393
Price to Book (FY) 0.0006
Price to Sales (FY) 0.1562
Balance Sheet
Quick Ratio (MRQ) 5.1710
Current Ratio (MRQ) 5.3314
Debt to Equity Ratio (MRQ) 0
Net Debt (MRQ) -29.972M
Total Debt (MRQ) 0
Total Assets (MRQ) 90.533M
Operating Metrics
Return on Assets (TTM) 0.2793
Return on Equity (TTM) 0.3277
Return on Invested Capital (TTM) 0.3302
Revenue per Employee (TTM) 619789.5000
Price History
Average Volume (10 day) 17.276M
1-Year Beta —
52 Week High 0.0393
52 Week Low 0.0002
Dividends
Dividends Paid (FY) —
Dividends Yield (FY) —
Dividends per Share (FY) 0
Dividends Expected (Annual) —
Margins
Net Margin (TTM) 0.1985
Gross Margin (TTM) 0.4323
Operating Margin (TTM) 0.2583
Pretax Margin (TTM) 0.2623
Income Statement
Basic EPS (FY) 6.8309
Basic EPS (TTM) 7.9678
EPS Diluted (FY) 6.7845
Net Income (FY) 17.878M
EBITDA (TTM) 28.293M
Gross Profit (MRQ) 11.538M
Gross Profit (FY) 42.057M
Last Year Revenue (FY) 94.547M
Total Revenue (FY) 94.547M
Free Cash Flow (TTM) 2.929M
https://www.kaly-info.com/
KALY - Kali-Extracts Realizes 250% Revenue Growth From New Cannabis Business With Even More Dramatic Growth Anticipated In Second Half Of 2019
GlobeNewswire•August 22, 2019
https://finance.yahoo.com/news/kaly-kali-extracts-realizes-250-130000043.html
Is kali going to look at any patent infringement suits with all of this cbd extractions going on
https://finance.yahoo.com/news/kaly-kali-extracts-files-patent-132000575.html
GlobeNewswire•August 21, 2019
DALLAS, Aug. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed the company has filed a new patent application specifically on its formulation for symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company’s existing patented cannabis extraction process. The company has also filed to register a trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions. KALY plans to publish a website on Friday, August 23rd, dedicated to its new CBD formulation, RespRx, for treating symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The RespRx website to be published Friday will include details on KALY’s recent patent and trademark applications for the RespRx CBD formulation. The company first announced its RespRx CBD formulation yesterday in a comprehensive update on the company’s overall Biopharmaceutical Developments From Cannabis Extractions targeting over $170 billion treatment opportunities. Look for the new RespRx website on Friday to learn more in addition to seeing the company’s up-to-date corporate financials intended for publication tomorrow.
To learn more about the company visit https://www.kali-extracts.com/.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
what would be a fair take out offer for fuelcell be say with exxon
are earnings report coming out today
SING should bottom fish take out beverage companies like TBEV which already has product lines in place but just didn't execute good marketing
CLOSING IN ON 30 MILLION SHARES
lets break .03 buy noon
21 million volume first hour of trade
VOLUME 12 MILLION 15 MINUTES
VOLUME 10 MILLION 15 MINUTES
So with these 2 contracts it should give a base price of .07 per share
ne 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American Premium Water Corporation (OTC: HIPH) announces the distribution of Canyon Create’s varicose vein cosmetic treatment, Vanexxe, is now available for sale on Walmart.com (https://www.walmart.com/ip/Vanexxe-Varicose-Vein-Support-Gel/867729968).
American Premium CEO, Ryan Fishoff , commented, “We are pleased that our partner Canyon Create’s Vanexxe is on WalMart.com! This is a huge accomplishment for them and great exposure for the product, which we anticipate benefit our Company’s marketing. Vanexxe is a revolutionary product that is entering the marketplace unchallenged; there is nothing like it that cosmetically addresses painful and unsightly varicose veins. Both Canyon and American Premium Water view this as just the first of a multi-tier, multi-national rollout strategy for the product.”
Campbell Mcauley, Founder, Canyon Create, commented, “This is an exciting time for us! We are thrilled to launch Vanexxe on Wal-Mart.com and look forward to seeing what American Premium Water can do through their other sales and distribution network in North America . No other solution performs like Vanexxe on the market; We are excited to introduce customers to this game changing product that cosmetically solves unsightly varicose veins.”
According to Canyon, Vanexxe (www.vanexxe.com) uses a proprietary formulation to eliminate the appearance of varicose veins. The product works by simultaneously brings heightened blood flow to the bulged vein valve, allowing it to pull away from the dermis and return to a more normal condition, and increases the elasticity in the upper skin layers to provide healthier skin, assisting in moving the vein back to a non-visible location. The Company made the licensing agreement with Canyon Create back in November 2018 .
Mr Fishoff stated: “Our licensing arrangement with Canyon Create is the first of what I believe to be many positive developments. The Company is going to continue to push distribution in other channels and are negotiating to bring to market other products that Canyon currently has in development. We are continuing to focus on expanding distribution and having a diverse portfolio of products provides us more ammunition when going to big box retailers. The strategy of making acquisitions with unique technology is generating benefits for the company, and in turn, could continue to propel shareholder value. The Company is simultaneously working on many strategic initiatives. We are also in discussions about other potential distribution deals across multiple product categories with other retailers, and I look forward to providing updates to investors when appropriate. When all is said and done, I hope we can carve out our own path and create a value that is second to none.”
get 50 people buy $100.00 dollar worth add .001 per trade we will be at silver LOL
LETS SEE SILVER BY 4TH OF JULY
International Spirits & Beverage Group, Inc.
ISBG
removed Caveat Emptor
Pink Curent
5/3/2019
ISBG Caveat Emptor Removed, Affirms Growth Outlook and Fully Current Status
9:40 am ET May 7, 2019 (Globe Newswire) Print
via OTC PR WIRE -- International Spirits and Beverage Group Inc. (OTCMKTS: ISBG) ("ISBG" or the "Company"), a top-tier brand incubator in the Adult Beverage and CBD-Infused Products markets, is proud to announce that the Caveat Emptor designation from the OTC Markets Group (the "OTC") has been officially removed and the Company is fully current on its financial reporting.
"We would like to thank the excellent team at the OTC for working with us diligently to correct our misunderstanding, file all necessary records, and affirm our fully current status," commented ISBG CEO Terry Williams. "We continue to drive value for our shareholders through both our Adult Beverage and Health and Wellness divisions, and we have never been so optimistic about the Company's growth potential as we look ahead to coming quarters. As such, it's particularly exciting to shed the extra weight of this designation and focus 100% of our energy on maximizing returns."
The Company has recently completed a major production run with its premium Besado Tequila brand, incorporating leading-edge Internet-of-Things and blockchain technology in the process to streamline costs and ensure the most optimal customer quality control as the product moves from raw inputs to customer end-market interactions.
In addition, the Company's enormous strides in its Health and Wellness division continue to drive much of the growth function for its robust 2019 revenue path. The introduction of its "P19" branded line of CBD-based products continues to gain market traction, and the company plans to further build out the diversity of this offering given the quick traction established by its initial products in the marketplace.
Management also notes that the dramatic growth context now characterizing the cannabis, hemp, and CBD industries - with some analysts now calling for as much as 20x growth in the CBD space alone over the next 36 months following the signing of the US Farm Bill in December - has introduced a dangerous dynamic of "pretenders" in the marketplace, making it all the more important for ISBG to maintain its first-rate standing and credible and transparent financial data with the OTC.
"According to the analysts, every dollar invested in the CBD market right now could be worth as much as twenty times that much in a very short time," continued Mr. Williams. "It is our responsibility to deliver that result to our shareholders. Resolving these issues with the OTC team invites institutional investors, a broader shareholder base, and greater credibility with the Company's partners, clients, stakeholders, and customers, so we can get back to optimizing our path forward, armed with some best-in-class logistics technology to fully monetize our huge strides in topline growth."
About ISBG: International Spirits and Beverage Group (ISBG) is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. Based in Nevada, the Company's expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISBG intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. In addition, ISBG has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company's website, as well as through established wholesale and retail distribution channels. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
PURA and KALY CBD Infused Beverages and Confections Validated With Chips Ahoy and Nilla Wafers
11:28 am ET May 3, 2019 (Globe Newswire) Print
via OTC PR WIRE -- Puration, Inc. (USOTC: PURA ("PURA") and Kali-Extracts (Kali, Inc. aka Kali-Extracts) (USOTC: KALY) ("KALY") today issued a joint communication to shareholders regarding the news about Mondelez International adding CBD to some of its products. News out yesterday reported that Mondelez International, the maker of Chips Ahoy, Oreo, Cadbury chocolate, Nilla Wafers and Nutter Butter cookies, is considering adding CBD to some of its products.
"Yes, we're getting ready, but we obviously want to stay within what is legal and play it the right way," Van de Put [Mondelez CEO Dirk Van de Put] told CNBC.
PURA has the only license of U.S. Patented Cannabis Extraction process owned by KALY. PURA now has two years of experience producing and refining a CBD infused beverage, EVERx CBD Sports Water. PURA has worked closely with KALY to refine its EVERx CBD Sports Water into the leading CBD infused beverage in the sports nutrition market in addition to developing new CBD infused beverages to be introduced soon. PURA reported over $1 million in sales in 2018. With PURA contributing production experience and capacity, KALY has introduced its own CBD infused confections under the brand name Hemp4mula starting first with Hemp4Mula gum. PURA's EVERx CBD Sports Water and KALY's Hemp4mula gum are available for sale today online at www.USMJ.com. The USMJ Ecommerce site comes from North American Cannabis Holdings, Inc. (aka USMJ) (USOTC: USMJ) ("USMJ").
PURA and KALY continue to work closely together on their years long strategy to introduce leading CBD infused products to market. Management of the two companies see the Mondelez news as a validation of PURA and KALY's business strategies and progress. Management of the two companies anticipate that developments such as the recent news from Mondelez will bode well for PURA and KALY in the form of garnering new investment to fuel business expansion and in regard to growing consumer demand for CBD infused products.
nov 8 AmeriCanna Cafe Spinoff and Dividend Affected in Transaction With PJET
The spinoff announced today has been affected through the execution of a securities exchange agreement between USMJ and PJET. USMJ has sold its AmeriCanna Cafe business in exchange for a convertible purchase note issued by PJET. Neither USMJ nor PJET are executing a reverse split in conjunction with this transaction. USMJ and PJET do plan to promptly convert the $1.5 million note into a number of common PJET shares sufficient to issue one PJET common share for every fifty shares of USMJ common shares issued and outstanding. All of the PJET common shares issued in conversion of the purchase note are slated for distributed to USMJ shareholders in a dividend distribution.
GlobeNewswire•November 9, 2018
New York, NY, Nov. 09, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GoIP Global Inc. (GOIG) announced today that the company has filed the required application and submitted the fee payment to OTC Markets to regain current status. This action is taken in line with our recently announced merger with CUBEIT; the company expects OTC Markets to update the company status within the next few days. The company is also in the process of engaging a PCAOB Auditing firm and will have an update regarding this shortly.
"The company looks forward to certain corporate updates for our shareholders specific to the business of CUBEIT short term as well," Mr. Ike Sutton, CEO of GOIP, stated. “I will be working diligently to bring this transaction to a formal close on or ahead of schedule, and again reiterate my enthusiasm for this opportunity.”
Overall Average:
96% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
dpends if you have carry over loses also